MeSH tree: D13.444.154
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence within the bladder, according ...
Feb 27, 2026
0
28
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across ...
Feb 26, 2026
0
11
A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it.
Feb 23, 2026
0
12
Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and Slovakia. They focused specifically ...
Feb 19, 2026
0
10
Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive form of the disease traditionally ...
Feb 19, 2026
0
9
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology. However, technological limitations with the small ...
Feb 17, 2026
0
13
Results from a pilot clinical trial evaluating the safety and feasibility of repeated focused ultrasound-induced blood–brain barrier (BBB) opening combined with the monoclonal antibody drug Avastin (bevacizumab) in patients ...
Feb 3, 2026
0
9
A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed 10 primary central nervous system lymphoma (PCNSL) patients who had difficult-to-access lesions ...
Jan 28, 2026
0
3
After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue. The molecule took the team on a six-year journey to systematically ...
Jan 23, 2026
0
16
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow. A team of researchers ...
Jan 17, 2026
0
16
